#United States #healthcare #San Francisco #Penumbra #thrombectomy

Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

Penumbra, Inc. (NYSE: PEN), a leader in thrombectomy solutions, has announced its upcoming presentation at the 44th Annual J.P. Morgan Healthcare Conference. This prestigious event will take place on January 12, 2026, at 6:45 PM Eastern Time, in San Francisco, California.

This conference is one of the most significant gatherings for healthcare investment and innovation, attracting stakeholders from across the industry. The management team of Penumbra is set to provide key insights into the company's advancements in medical technology, specifically focusing on their pioneering thrombectomy devices designed to address complex medical conditions such as ischemic strokes and thromboembolic disorders.

A Focus on Pioneering Medical Technology

Penumbra's reputation stems from its commitment to developing cutting-edge technologies. The company's portfolio features clinically advanced solutions like Computer Assisted Vacuum Thrombectomy (CAVT), which enhances the speed, safety, and efficacy of clot removal procedures. Their innovative products are designed to improve patient outcomes and quality of life, ensuring that healthcare providers around the globe have access to state-of-the-art tools for critical care.

The upcoming presentation at the J.P. Morgan Healthcare Conference provides an excellent platform for Penumbra to showcase its dedication to these advancements and their role in transforming patient care. The experience and expertise of the management team will highlight not only the technical capabilities of their products but also the positive impact they have on healthcare systems worldwide.

Access to the Presentation

For those unable to attend in person, Penumbra will be webcasting the presentation. Interested parties can access the live stream through the "Events and Presentations" section on the Investor Relations page of their website (www.penumbrainc.com). The recorded session will be available for viewing for at least two weeks following the event, ensuring that stakeholders can stay informed about the latest developments in their technology.

Commitment to Innovation and Patient Health

With operations in over 100 countries, Penumbra’s goal is to establish new standards for the medical device industry. Their focus on innovation reflects a growing understanding of patient needs and the challenges faced in acute medical situations. Their products are designed not just for effectiveness but also for ease of use, making them invaluable in emergency healthcare settings.

In summary, the 44th Annual J.P. Morgan Healthcare Conference presents an ideal venue for Penumbra, Inc. to articulate its strategic vision and showcase groundbreaking innovations. As the company continues to push the boundaries of thrombotic intervention, its leadership at this event will serve as a testament to their commitment to advancing healthcare technology. Stay tuned for updates as Penumbra leads the way in transforming medical practices worldwide.